Non-current assets |
|
|
|
Intangible assets and goodwill |
(12) |
14,185 |
15,215 |
Property, plant and equipment |
(13) |
27,855 |
28,720 |
Equity-accounted investments |
(14) |
971 |
1,456 |
Other non-current assets |
(18) |
67 |
70 |
|
|
43,078 |
45,462 |
|
|
|
|
Current assets |
|
|
|
Inventories |
(15) |
9,420 |
9,756 |
Trade receivables |
(16) |
7,798 |
9,442 |
Other current assets |
(18) |
818 |
691 |
Current tax assets |
(10) |
214 |
56 |
Other financial assets |
(17) |
238 |
178 |
Cash and cash equivalents |
(19) |
27,171 |
5,352 |
|
|
45,658 |
25,476 |
|
|
|
|
ASSETS |
|
88,737 |
70,937 |
|
|
|
|
Equity |
(20) |
|
|
Subscribed capital |
|
21,847 |
21,847 |
Capital reserves |
|
94,951 |
93,457 |
Retained earnings |
|
-105,494 |
-94,161 |
Other reserves |
|
1,313 |
627 |
|
|
12,617 |
21,771 |
Non-controlling interests |
|
1,269 |
1,243 |
Total equity |
|
13,886 |
23,013 |
|
|
|
|
Non-current liabilities |
|
|
|
Deferred tax |
(10) |
3,881 |
3,768 |
Provisions for post-employment benefits for employees |
(5) |
930 |
928 |
Financial liabilities |
(21) |
21,175 |
24,265 |
Convertible bonds |
(22) |
4,151 |
0 |
Financial liability to Royalty Pharma |
(23) |
18,406 |
0 |
Other liabilities |
(24) |
179 |
966 |
Deferred income |
(25) |
1,124 |
518 |
|
|
49,845 |
30,445 |
|
|
|
|
Current liabilities |
|
|
|
Provisions |
(26) |
1,106 |
895 |
Tax liabilities |
(10) |
24 |
44 |
Financial liabilities |
(21) |
11,888 |
4,741 |
Convertible bonds |
(22) |
326 |
0 |
Trade payables |
(27) |
5,611 |
5,617 |
Other liabilities |
(24) |
5,431 |
3,251 |
Deferred income |
(25) |
620 |
2,932 |
|
|
25,006 |
17,479 |
|
|
|
|
EQUITY AND LIABILITIES |
|
88,737 |
70,937 |